成人直播

Thursday, April 16, 2026
PhD student Zach Whiddon
NIH funds UofL doctoral students鈥 work on taste buds and brain circuitry
You may be confident in your potential to pursue a career in biomedical research when the National Institutes of Health funds your work before...
UofL Trager Institute
UofL Trager Institute uses technology to reduce social isolation for older adults Initiatives to benefit older adults during pandemic to be discussed in weekly information session Aug. 4
Amid efforts to stem the spread of the COVID-19 pandemic, social isolation and loneliness have emerged as a significant public health crisis, particularly for...
Cardinal Anti-Racism Agenda launch.
President Bendapudi announces plan for UofL to become 鈥榩remier anti-racist metropolitan research university鈥
University of Louisville President Neeli Bendapudi today announced a goal to become the 鈥減remier anti-racist metropolitan research university in the country.鈥 To guide us toward...
Allen Morris, executive director of the UofL Commercialization EPI-Center
UofL, partners will help commercialize Kentucky university-born technologies New effort, backed by $1.15 million from the Commonwealth, will encourage growth of innovative companies in Kentucky
The University of Louisville and partners will lead an effort to bring technologies born at Kentucky universities to market, thanks to $1.16 million in...
Map 2: Prevalence of COVID-19 in Jefferson County in June 2020.
Phase II results of Co-Immunity Project show higher-than-expected rates of coronavirus exposure in Jefferson County
Results from the second phase of the University of Louisville鈥檚 groundbreaking project to track COVID-19 in Jefferson County show that 4 to 6 times...
Geoffrey Clark, Ph.D.
UofL technology that may inhibit pathway for cancer gets commercial partner Researchers say the technology could solve 鈥渙ne of the holy grails鈥 of cancer treatment
NA University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company focused on developing...
A clinical trial for Aviptadil (RLF-100) is underway at UofL for severe COVID-19 patients. Image courtesy NeuroRx.
UofL conducting clinical trial on drug for severe COVID-19 respiratory effects
The University of Louisville is conducting a clinical trial on a new treatment for critically ill COVID-19 patients meant to lessen some of the...
UofL researcher examines school resource officers’ approach to students of different races
A recently published study by a UofL professor discovered school resource officers assess threats differently based on the racial makeup of their school. In 鈥淧rotecting...
Diagram showing levels of neutrophil immune cells (red dots) in a healthy donor, a patient with moderate COVID-19 and a patient with severe COVID-19. Data analysis by Corey T. Watson, Ph.D., David Tieri, Ph.D., and M.D./Ph.D. student Anne Geller.
UofL immunologist discovers biomarker that predicts a crisis in COVID-19 patients
Dr. Jun Yan, professor of surgery and microbiology and immunology at the University of Louisville, led a team of researchers in the discovery of...
Woman with vape
UofL researchers part of a nearly $17 million investment to fast-track studies on effects of vaping, nicotine on youth
The American Heart Association is investing nearly $17 million to fund a two-year research initiative, ENACT (End Nicotine Addiction in Children and Teens), led...